{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:41:13Z","timestamp":1791906073624,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.ijantimicag.2007.04.004","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T15:36:50Z","timestamp":1181230610000},"page":"157-161","source":"Crossref","is-referenced-by-count":43,"title":["In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis"],"prefix":"10.1016","volume":"30","author":[{"given":"A.J.","family":"Carrillo-Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Giusiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Guarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Quind\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Guardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"del Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Estivill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.D.","family":"C\u00e1rdenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2007.04.004_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1130-1406(05)70032-2","article-title":"Revisiting the epidemiology of onychomycoses","volume":"22","author":"Arrese","year":"2005","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S1130-1406(05)70004-8","article-title":"Fungal infection of the feet in soccer players and non-athlete individuals","volume":"22","author":"Purim","year":"2005","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/13693780601070107","article-title":"Analysis of the dermatophyte species isolated in the British Isles between 1980 and 2005 and review of worldwide dermatophyte trends over the last three decades","volume":"45","author":"Borman","year":"2007","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/13693780500536893","article-title":"In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes","volume":"44","author":"Santos","year":"2006","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1439-0507.2005.01161.x","article-title":"Onychomycosis in children: a survey of 46 cases","volume":"48","author":"Romano","year":"2005","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib6","series-title":"Biology of dermatophytes and other keratinophilic fungi","first-page":"148","article-title":"Trends in the treatment of dermatophytoses","author":"del Palacio","year":"2000"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib7","first-page":"1","article-title":"Voriconazole in the management of nosocomial invasive fungal infections","volume":"2","author":"Pem\u00e1n","year":"2006","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib8","first-page":"108","article-title":"Antifungal activity of voriconazole against dermatophytes and Scopulariopsis brevicaulis determined by an agar diffusion method (NeoSensitabs\u00ae)","volume":"22","author":"Carrillo-Mu\u00f1oz","year":"2005","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1568012043353766","article-title":"Current developments in antifungal agents","volume":"3","author":"Carrillo-Mu\u00f1oz","year":"2004","journal-title":"Curr Med Chem Anti Infect Agents"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib10","unstructured":"National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. Wayne, PA: NCCLS; 2002."},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib11","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1128\/JCM.40.11.3999-4003.2002","article-title":"Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes","volume":"40","author":"Fern\u00e1ndez-Torres","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib12","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1128\/AAC.45.9.2524-2528.2001","article-title":"In vitro activities of 10 antifungal drugs against 508 strains of dermatophytes","volume":"45","author":"Fern\u00e1ndez-Torres","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2133.2001.145s60021.x","article-title":"Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain","volume":"145","author":"Lecha","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib14","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1128\/JCM.00818-06","article-title":"Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial","volume":"44","author":"Ghannoum","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1128\/JCM.39.1.385-388.2001","article-title":"Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method","volume":"39","author":"Perea","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1157\/13052331","article-title":"In vitro activity of voriconazole and three other antifungal agents against dermatophytes","volume":"21","author":"Serrano-Martino","year":"2003","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jac\/dki100","article-title":"A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus","volume":"55","author":"Krishnan","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib18","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1128\/AAC.39.5.1206","article-title":"Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. German Collaborative Dermatophyte Drug Susceptibility Study Group","volume":"39","author":"Korting","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib19","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/AAC.43.6.1520","article-title":"In vitro antifungal susceptibilities of Scopulariopsis isolates","volume":"43","author":"Aguilar","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib20","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1128\/AAC.43.5.1260","article-title":"In vitro activity of Syn-2869, a novel triazole agent, against emerging and less common mould pathogens","volume":"43","author":"Johnson","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1439-0507.1998.tb00344.x","article-title":"In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin","volume":"41","author":"Wildfeuer","year":"1998","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1439-0507.1999.tb00026.x","article-title":"Activity of terbinafine against serious fungal pathogens","volume":"42","author":"Ryder","year":"1999","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2007.04.004_bib23","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1128\/AAC.00162-06","article-title":"In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis","volume":"50","author":"Cuenca-Estrella","year":"2006","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907002014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907002014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T16:36:06Z","timestamp":1556469366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857907002014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0924857907002014"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.04.004","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}